Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

2.

Continuous subcutaneous infusion of insulin lispro in children and adolescents with type 1 diabetes mellitus.

Kaiserman K, Rodriguez H, Stephenson A, Wolka L, Fahrbach JL.

Endocr Pract. 2012 May-Jun;18(3):418-24. doi: 10.4158/EP11265.RA. Review.

PMID:
22297055
3.

Long-term compliance of intensified insulin therapy.

Schifferdecker E, Schmidt K, Boehm BO, Schatz H.

Diabetes Res Clin Pract. 1994 Feb;23(1):17-23. Review.

PMID:
8013259
5.
6.

Guidelines for using insulin lispro.

Toth EL, Lee KC.

Can Fam Physician. 1998 Nov;44:2444-9. Review.

7.

[How should we use the short-acting insulin analog Lys-Pro in external continuous subcutaneous pumps?].

Guerci B, Jeandidier N, Lassmann-Vague V, Renard E, Hanaire-Broutin H.

Diabetes Metab. 2000 Dec;26(6):513-9. Review. French. Erratum in: Diabetes Metab 2001 Feb;27(1):86.

PMID:
11173725
8.
9.

Alternative insulin delivery systems: how demanding should the patient be?

Polonsky KS, Byrne MM, Sturis J.

Diabetologia. 1997 Jul;40 Suppl 2:S97-101. Review. No abstract available.

PMID:
9248709
10.

Meticulous glucose control in diabetic persons using insulin.

Wender RC.

Compr Ther. 1988 Sep;14(9):16-25. Review.

PMID:
3064959
11.

Insulin analogues--patient preference may drive prescribing.

Thompson C.

Ir Med J. 1998 Jan-Feb;91(1):16-7. Review. No abstract available.

PMID:
9563247
12.

[Lispro-insulin analogs in therapy of diabetes].

Rosenberger JS, Eibl N, Schernthaner G.

Wien Klin Wochenschr. 1997 Dec 12;109(23):910-8. Review. German.

PMID:
9487605
13.
14.

Critical evaluation of concepts of insulin therapy.

Waldhäusl WK.

Life Support Syst. 1985;3 Suppl 1:507-18. Review. No abstract available.

PMID:
3916616

Supplemental Content

Support Center